Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 7, 2023
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
Aydin Huseynov Initiated (ADVM) at Strong Buy and Held Target at $20 on, Mar 7th, 2023
Aydin Huseynov of Ladenburg Thalmann, Initiated "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy and Held Target at $20 on, Mar 7th, 2023.
Aydin has made no other calls on ADVM in the last 4 months.
There are 2 other peers that have a rating on ADVM. Out of the 2 peers that are also analyzing ADVM, all agree with Aydin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Daniil Gataulin of "Chardan Capital" Maintained at Hold with Decreased Target to $20 on, Friday, November 11th, 2022
- Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $30 on, Friday, November 11th, 2022
